Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs MRNA✓SelectedUSD · MRNALLY vs MRNA performance historyLatest closeAs of-0.82%11/16
Stock and ETF performance explorer

LLY vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,293.9%
MRNA return
+878.5%
Excess return
+415.4%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.8%-3.6%+2.8%-0.7%
7D+1.5%-20.0%+21.5%+2.5%
30D+14.0%-1.3%+15.3%+13.9%
3M+21.5%+240.0%-218.5%+11.3%
6M+42.8%+339.0%-296.1%+28.7%
YTD+34.0%+630.0%-596.0%+17.1%
1Y+40.5%+769.1%-728.6%+21.5%
3Y+148.1%+181.2%-33.1%+120.2%
5Y+480.1%-8.1%+488.2%+431.9%
All+1,293.9%+878.5%+415.4%+965.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling